U.S. Metals and Mining Stock News

T-Mobile US recently unveiled an aggressive holiday switching campaign, including a 15-minute sign-up via its T-Life app and a limited-time free iPhone 17 256GB offer for new customers who port their numbers and enroll in specific plans, while also approving a new US$14.60 billion shareholder return program through 2026 via buybacks and dividends. These moves, alongside intensified competitive poaching across US wireless carriers, position T-Mobile as an operator using both customer...

In mid-December 2025, Charles River Laboratories International received a series of analyst upgrades and benefited from the U.S. SEC closing its investigation without recommending enforcement action, boosting confidence in its operations and governance. These developments eased regulatory uncertainty and reinforced the company’s role as a key contract research partner for complex preclinical and early-stage drug development work. We’ll now examine how the SEC clearance and recent analyst...

If you are wondering whether General Motors is still a value play after its big run, you are in the right place. We are going to unpack what the current price really implies. The stock has climbed 6.0% over the last week, 15.9% over the past month, and 59.2% year to date, contributing to a 61.5% gain over the last year and more than doubling investors' money over 3 and 5 years. Recently, markets have focused on GM's push into electric vehicles and software defined cars, along with ongoing...

TeraWulf (WULF) just took a hit as Bitcoin slid and the company pushed through a mandatory conversion of preferred shares into common stock, lifting the share count and sharpening investor focus on dilution. See our latest analysis for TeraWulf. The latest slide comes after a volatile stretch in which the 30 day share price return of 18.20 percent and year to date share price return of 137.91 percent contrast with a still strong 3 year total shareholder return of 2,136.19 percent. This...

LTC Properties (LTC) has quietly pulled back about 5% over the past month even as its annual revenue and net income each climbed roughly 35%, raising questions about whether investors are overlooking this healthcare REIT. See our latest analysis for LTC Properties. The recent pullback leaves LTC’s share price only modestly higher year to date, while a steadier three and five year total shareholder return suggests long term holders have still been rewarded even as near term momentum cools. If...

ServisFirst Bancshares (SFBS) has quietly bounced about 5 % over the past month even as its year to date performance remains weak, inviting a closer look at what investors might be pricing in now. See our latest analysis for ServisFirst Bancshares. The recent 1 month share price return of about 5 % looks more like a tentative rebound than a full trend change, with the year to date share price still down double digits and the 1 year total shareholder return negative despite a solid 5 year...

If you are wondering whether Advanced Energy Industries is still worth buying after its big run up, or if the smarter move now is to wait for a better entry point, you are not alone. The stock has cooled slightly over the last week, down 2.8%, but it is still up 6.3% over the last month, 86.5% year to date, and 78.8% over the past year. Longer term, its 3-year and 5-year returns are 153.9% and 124.0% respectively. Recent attention around Advanced Energy has focused on its position as a key...

BioCryst Pharmaceuticals has received FDA approval for an oral pellet formulation of once-daily ORLADEYO (berotralstat) to prevent hereditary angioedema attacks in children aged 2 to under 12, making it the first targeted oral prophylactic option for this younger pediatric group. This child-friendly formulation, backed by the APeX-P trial showing sustained reductions in monthly attack rates and a consistent safety profile, meaningfully broadens ORLADEYO’s reach in hereditary angioedema...

White Mountains Insurance Group (WTM) has quietly delivered strong multi year returns, and the stock’s recent climb adds fresh interest. Investors are now weighing how much of that performance is already priced in. See our latest analysis for White Mountains Insurance Group. Over the past year, White Mountains’ steady 90 day share price return of 18.71 percent and solid 5 year total shareholder return of 106.35 percent suggest momentum is still building rather than fading at the current share...

United Natural Foods (UNFI) put fresh numbers behind its long term story at its 2025 investor day, outlining steady sales growth and a significantly higher EBITDA goal that has analysts revisiting their outlook. See our latest analysis for United Natural Foods. The stock has pulled back, with a 1 month share price return of minus 14.9 percent after a strong run. However, its year to date share price return of 19.1 percent and 5 year total shareholder return of 107.3 percent suggest longer...

Iridium Communications (IRDM) just gave investors two fresh talking points, pairing a new 0.15 dollar quarterly dividend with the appointment of seasoned tech executive Louis Alterman to its expanded board. See our latest analysis for Iridium Communications. Even with the new dividend and board upgrade, sentiment is still catching up. The latest 1 year total shareholder return of about negative 41 percent reflects fading momentum after a much steeper year to date share price pullback. If...

Earlier in December 2025, the U.S. Air Force Life Cycle Management Center awarded V2X, Inc. a position on the Automated Test Systems Division’s multiple-award IDIQ contract, enabling the company to provide rapid, full lifecycle support for test systems across a broad range of manned and unmanned aircraft platforms worldwide. This long-duration, flexible contract, spanning an initial five-year base period with an option for another five years, highlights V2X’s role in sustaining...

IREN (NasdaqGS:IREN) just pulled off a rare combo, landing a $9.7 billion multi year AI cloud deal with Microsoft and backing it up with a $3.6 billion capital raise to fund massive GPU and data center expansion. See our latest analysis for IREN. The share price has been choppy around the latest capital raise and Microsoft deal, with a 7 day share price return of minus 21.88 percent but a year to date share price return of 249.81 percent and a three year total shareholder return of 2,513.57...

Blackstone (BX) just helped Sumitomo Mitsui complete a landmark $3.2 billion synthetic risk transfer while also striking a forward flow deal for first lien commercial mortgages, moves that quietly deepen its influence across global credit markets. See our latest analysis for Blackstone. These deals land at a moment when Blackstone’s 30 day share price return of 7.53 percent contrasts with a softer 90 day share price return of negative 17.17 percent. At the same time, its five year total...

Amdocs (DOX) just wrapped up FY 2025 with fourth quarter revenue of about $1.2 billion and EPS of $0.88, setting the stage against a trailing twelve month backdrop of $4.5 billion in revenue and EPS of $5.08. Over the past year, the company has seen revenue move from roughly $5.0 billion to $4.5 billion on a trailing basis, while trailing EPS has edged up from $4.27 to $5.08. This reflects a business that is leaning more on profitability than top line expansion, with margins now doing more of...

XPeng (NYSE:XPEV) is back in the spotlight after signing a strategic manufacturing deal in Malaysia, adding a new production hub just as the stock digests a sharp short term pullback. See our latest analysis for XPeng. The Malaysia deal lands just as XPeng’s 30 day share price return of negative 26.15 percent and 90 day share price return of negative 14.49 percent contrast with a much stronger 59.91 percent year to date share price return and 43.85 percent one year total shareholder return...

OneWater Marine (ONEW) just closed out FY 2025 with fourth quarter revenue of $460.1 million and basic EPS of about -$6.90, capping a year in which trailing twelve month revenue came in at roughly $1.9 billion and EPS was -$7.22. Over the past few quarters the company has seen revenue move from $375.8 million in Q1 2025 to $552.9 million in Q3 2025 before landing at $460.1 million in Q4, while EPS has swung from -$0.81 to $0.66 and back down sharply. That mix of solid top line scale and...

B. Riley Financial (RILY) has swung back to positive quarterly earnings in Q2 2025, posting revenue of about $199 million and EPS of roughly $2.23, even as trailing 12 month figures still reflect sizable losses. The company has seen revenue move from about $38 million in Q2 2024 to nearly $199 million in Q2 2025, while quarterly EPS has shifted from roughly negative $14.86 to positive $2.23. This sets up a sharp contrast between the latest quarter and its loss making recent history and puts...

CSPI (CSPI) has just wrapped up FY 2025 with fourth quarter revenue of about $14.5 million and a basic EPS loss of roughly $0.02, while trailing 12 month revenue sits near $58.7 million with a small net loss of about $0.1 million. The company has seen quarterly revenue move in a fairly tight band between roughly $13.1 million and $15.7 million over the last year, with EPS swinging from a $0.05 profit in Q1 2025 to modest losses in the subsequent quarters. This sets up a story that is really...

If you are looking at Assurant and wondering whether the current price really reflects its long term potential, you are not alone. This article is going to unpack exactly that. The stock has climbed to around $233.32, delivering 4.9% over the last week, 10.4% year to date, and 101.3% over 3 years. This naturally raises the question of whether the market is now getting ahead of itself. Recent moves in Assurant have been shaped by a steady drumbeat of positive sentiment around its specialty...

Bilibili (NasdaqGS:BILI) has quietly slid over the past month, even as its year to date performance and double digit revenue and net income growth paint a more balanced picture for long term investors. See our latest analysis for Bilibili. At around $24.39 per share, the recent 30 day share price return of minus 6.84 percent and 90 day share price return of minus 12.96 percent suggest fading near term momentum, even though the year to date share price return of 42.38 percent and one year...

Earlier this month, Oklo Inc. filed a very large US$1.50 billion at-the-market Class A common stock offering to fund its capital-intensive advanced nuclear build-out while still pre-revenue. At the same time, reports of Oracle delaying key AI data center projects to 2028 have raised fresh questions about the timing of demand for Oklo’s planned microreactors. We’ll now examine how the combination of Oracle’s delayed AI data centers and Oklo’s sizable equity program shapes its investment...

Cidara Therapeutics (CDTX) has quietly delivered striking long term gains, with the stock up sharply over the past year and even more over the past 3 years, despite ongoing losses. See our latest analysis for Cidara Therapeutics. Most of that excitement is baked into the recent move, with a roughly 239 percent 3 month share price return feeding into an 864 percent 1 year total shareholder return. This suggests momentum is still very much with the bulls. If Cidara’s surge has you thinking more...

ADT (ADT) shares have been drifting lately, and that sideways action is starting to look interesting when you line it up with the company’s improving fundamentals and still modest valuation profile. See our latest analysis for ADT. At around $8.14 per share, ADT’s solid year to date share price return contrasts with its softer three year total shareholder return. This suggests sentiment has improved recently as investors reassess its growth and risk profile. If ADT’s steady reset has your...